Impaired dendritic cell function in aging leads to defective antitumor immunity

Cancer Research

Volumn 68, Issue 15, 2008, Pages 6341-6349

  Grolleau Julius, Annabelle ^a   Harning, Erin K ^a   Abernathy, Lisa M ^a   Yung, Raymond L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; OVALBUMIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CANCER EPIDEMIOLOGY; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; EFFECTOR CELL; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; VACCINATION; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

AGING; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; DENDRITIC CELLS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MICE; MICE, INBRED C57BL; OVALBUMIN;

EID: 51049091671     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-5769     Document Type: Article

References (33)

1. Yung RL. Changes in immune function with age. Rheum Dis Clin North Am 2000;26:455-73.
2. Miller RA. The aging immune system: primer and prospectus. Science 1996;273:70-4.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
4. Palucka K, Banchereau J. Dendritic cells: a link between innate and adaptive immunity. J Clin Immunol 1999;19:12-25.
5. Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005;5:296-306.
6. Grolleau A, Sloan A, Mule JJ. Dendritic cell-based vaccines for cancer therapy. Cancer Treat Res 2005;123:181-205.
7. Agrawal A, Agrawal S, Gupta S. Dendritic cells in human aging. Exp Gerontol 2007;42:421-6.
8. Agrawal A, Agrawal S, Tay J, Gupta S. Biology of dendritic cells in aging. J Clin Immunol 2008;28:14-20.
9. Shurin MR, Shurin GV, Chatta GS. Aging and the dendritic cell system: implications for cancer. Crit Rev Oncol Hematol 2007;64:90-105.
10. Sharma S, Dominguez AL, Lustgarten J. Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp Gerontol 2006;41:78-84.
11. + NKT cells. Exp Oncol 2005;27:125-9.
12. - dendritic cell function. J Gerontol A Biol Sci Med Sci 2006;61:1039-47.
13. Grolleau A, Misek DE, Kuick R, Hanash S, Mule JJ. Inducible expression of macrophage receptor Marco by dendritic cells following phagocytic uptake of dead cells uncovered by oligonucleotide arrays. J Immunol 2003;171:2879-88.
14. Mo R, Chen J, Grolleau-Julius A, Murphy HS, Richardson BC, Yung RL. Estrogen regulates CCR gene expression and function in T lymphocytes. J Immunol 2005;174:6023-9.
15. Shimizu K, Thomas EK, Giedlin M, Mule JJ. Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein. Cancer Res 2001;61:2618-24.
16. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 2005;5:617-28.
17. Gunn MD, Kyuwa S, Tam C, et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999;189:451-60.
18. Becker C, Pohla H, Frankenberger B, et al. Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay. Nat Med 2001;7:1159-62.
19. Lung TL, Saurwein-Teissl M, Parson W, Schonitzer D, Grubeck-Loebenstein B. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 2000;18:1606-12.
20. Saurwein-Teissl M, Schonitzer D, Grubeck-Loebenstein B. Dendritic cell responsiveness to stimulation with influenza vaccine is unimpaired in old age. Exp Gerontol 1998;33:625-31.
21. Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol 2007;178:6912-22.
22. Choi KL, Sauder DN. Epidermal Langerhans cell density and contact sensitivity in young and aged BALB/c mice. Mech Ageing Dev 1987;39:69-79.
23. Sprecher E, Becker Y, Kraal G, Hall E, Harrison D, Shultz LD. Effect of aging on epidermal dendritic cell populations in C57BL/6J mice. J Invest Dermatol 1990;94:247-53.
24. Shodell M, Siegal FP. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol 2002;56:518-21.
25. Linton PJ, Li SP, Zhang Y, Bautista B, Huynh Q, Trinh T. Intrinsic versus environmental influences on T-cell responses in aging. Immunol Rev 2005;205:207-19.
26. Cumberbatch M, Dearman RJ, Kimber I. Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1β. Immunology 2002;105:466-77.
27. Bhushan M, Cumberbatch M, Dearman RJ, Kimber I, Griffiths CE. Exogenous interleukin-1β restores impaired Langerhans cell migration in aged skin. Br J Dermatol 2004;150:1217-8.
28. Micheletti F, Bazzaro M, Canella A, Marastoni M, Traniello S, Gavioli R. The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses. Immunology 1999;96:411-5.
29. Sambhara S, Kurichh A, Miranda R, et al. Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses. Cell Immunol 2001;210:1-4.
30. Geijtenbeek TB, Torensma R, van Vliet SJ, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000;100:575-85.
31. van Kooyk Y, Geijtenbeek TB. A novel adhesion pathway that regulates dendritic cell trafficking and T cell interactions. Immunol Rev 2002;186:47-56.
32. van Gisbergen KP, Paessens LC, Geijtenbeek TB, van Kooyk Y. Molecular mechanisms that set the stage for DC-T cell engagement. Immunol Lett 2005;97:199-208.
33. Gijzen K, Tacken PJ, Zimmerman A, et al. Relevance of DC-SIGN in DC-induced T cell proliferation. J Leukoc Biol 2007;81:729-40.